PTH Among Health Care ETFs
End-of-day Nov 20, 2026 · 27 Health care ETFs by 5Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.2% | −7.2% | −9.7% | −14.7% | +7.0% | +8.0% | +70.0% | +1.1% | +238.6% | +561.7% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$50 of every $1,000 in PTH is Insmed
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | INSMInsmed | Healthcare | 5.02% | $501.83 | 93K | $13.4M |
| 2 | ROIVRoivant Sciences | Healthcare | 4.39% | $439.36 | 300K | $11.7M |
| 3 | THCTenet Healthcare | Healthcare | 4.02% | $401.68 | 41K | $10.7M |
| 4 | GHGuardant Health | Healthcare | 3.48% | $348.13 | 64K | $9.3M |
| 5 | AXGNAxogen | Healthcare | 3.37% | $336.81 | 159K | $9.0M |
| 6 | RVMDRevolution Medicines | Healthcare | 3.28% | $327.89 | 55K | $8.7M |
| 7 | MEDPMedpace | Healthcare | 3.12% | $311.94 | 13K | $8.3M |
| 8 | TXG10X Genomics | Healthcare | 3.07% | $307.40 | 143K | $8.2M |
| 9 | NTRANatera | Healthcare | 2.95% | $295.06 | 27K | $7.9M |
| 10 | EXELExelixis | Healthcare | 2.89% | $289.08 | 117K | $7.7M |
| 11 | HNGEHinge Health | Healthcare | 2.88% | $288.09 | 71K | $7.7M |
| 12 | IOVAIovance Biotherapeutics | Healthcare | 2.73% | $272.76 | 994K | $7.3M |
| 13 | CRLCharles River Laboratories International | Healthcare | 2.49% | $249.23 | 20K | $6.6M |
| 14 | CDNACareDx | Healthcare | 2.48% | $247.51 | 92K | $6.6M |
| 15 | TWSTTwist Bioscience | Healthcare | 2.41% | $240.63 | 57K | $6.4M |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | INSM | Insmed | 5.02% |
| 2 | ROIV | Roivant Sciences | 4.39% |
| 3 | THC | Tenet Healthcare | 4.02% |
| 4 | GH | Guardant Health | 3.48% |
| 5 | AXGN | Axogen | 3.37% |
| 6 | RVMD | Revolution Medicines | 3.28% |
| 7 | MEDP | Medpace | 3.12% |
| 8 | TXG | 10X Genomics | 3.07% |
| 9 | NTRA | Natera | 2.95% |
| 10 | EXEL | Exelixis | 2.89% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 26, 2025 | $1.53 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0255 |
| Dec 20, 2013 | Dec 31, 2013 | $0.0114 |
| Sep 20, 2013 | Sep 30, 2013 | $0.0027 |
| Jun 21, 2013 | Jun 28, 2013 | $0.0368 |
| Dec 21, 2012 | Dec 31, 2012 | $0.11 |
| Jun 15, 2012 | Jun 29, 2012 | $0.0084 |
| Dec 18, 2009 | Dec 31, 2009 | $0.0194 |
| Jun 19, 2009 | Jun 30, 2009 | $0.0083 |